Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Elderly
  Childs:
  - Child:
      Genes: no data
      Label: Atypical progressive supranuclear palsy syndrome
      ORPHAcode: '99750'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Major susceptibility factor in
          ExternalReferences:
          - Reference: '6893'
            Source: HGNC
          - Reference: '157140'
            Source: OMIM
          Label: microtubule associated protein tau
          Symbol: MAPT
      Label: Classic progressive supranuclear palsy syndrome
      ORPHAcode: '240071'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '610898'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '260540'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '601104'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
        to represent it)
      Reference: '609454'
      Source: OMIM
  Label: Progressive supranuclear palsy
  ORPHAcode: '683'
  ORPHApacketId: '683'
  PURL: http://www.orpha.net/ORDO/Orphanet_683
  Parents:
  - Parent:
    - Label: Supranuclear eye movement disorder
      ORPHAcode: '98687'
  - Parent:
    - Label: Frontotemporal degeneration with dementia
      ORPHAcode: '98535'
  - Parent:
    - Label: Frontotemporal neurodegeneration with movement disorder
      ORPHAcode: '306708'
  - Parent:
    - Label: Genetic frontotemporal degeneration with dementia
      ORPHAcode: '276061'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000605
      HPOTerm: Supranuclear gaze palsy
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000623
      HPOTerm: Supranuclear ophthalmoplegia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002015
      HPOTerm: Dysphagia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002172
      HPOTerm: Postural instability
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002317
      HPOTerm: Unsteady gait
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002527
      HPOTerm: Falls
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002529
      HPOTerm: Neuronal loss in central nervous system
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012535
      HPOTerm: Abnormal synaptic transmission
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0100710
      HPOTerm: Impulsivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000505
      HPOTerm: Visual impairment
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000511
      HPOTerm: Vertical supranuclear gaze palsy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000514
      HPOTerm: Slow saccadic eye movements
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000643
      HPOTerm: Blepharospasm
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000712
      HPOTerm: Emotional lability
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000716
      HPOTerm: Depression
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000737
      HPOTerm: Irritability
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000741
      HPOTerm: Apathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000750
      HPOTerm: Delayed speech and language development
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001260
      HPOTerm: Dysarthria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001332
      HPOTerm: Dystonia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002067
      HPOTerm: Bradykinesia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002120
      HPOTerm: Cerebral cortical atrophy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002171
      HPOTerm: Gliosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002200
      HPOTerm: Pseudobulbar signs
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002321
      HPOTerm: Vertigo
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002354
      HPOTerm: Memory impairment
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002381
      HPOTerm: Aphasia
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100543
      HPOTerm: Cognitive impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000496
      HPOTerm: Abnormality of eye movement
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000726
      HPOTerm: Dementia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001337
      HPOTerm: Tremor
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002063
      HPOTerm: Rigidity
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11487180[PMID]_9371909[PMID]_4792160[PMID]_3405368[PMID]_6333204[PMID]_3386818[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 'PMID: 27037234  ; 34220661; ORPHANET'
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2015[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 3386818[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 9613728[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Guadeloupe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11912113[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21088431[PMID]_10577638[PMID]_11408338[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Libyan Arab Jamahiriya
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 3405368[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 6333204[PMID]_9371909[PMID]_3386818[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 4792160[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: PSP syndrome
  TextSection:
    Contents: A rare late-onset neurodegenerative disease characterized by ocular
      motor dysfunction postural instability akinesia-rigidity and cognitive dysfunction.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2025
  creationDate: '2025-06-26 11:48:15'
  version: 1.3.42 / 4.1.8 [2025-03-03]
